LPL Financial’s Verona Pharma VRNA Stock Holding History

LPL Financial’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,946	Closed	-$2.24M	–	6078
2025 Q3	$2.24M	Sell	20,946 -46,377	-69%	-$4.84M	﹤0.01%	3214
2025 Q2	$6.37M	Buy	67,323 +16,790	+33%	+$1.24M	﹤0.01%	2123
2025 Q1	$3.21M	Buy	50,533 +20,500	+68%	+$1.23M	﹤0.01%	2512
2024 Q4	$1.39M	Buy	30,033 +15,598	+108%	+$586K	﹤0.01%	3204
2024 Q3	$415K	Buy	14,435 +4,254	+42%	+$105K	﹤0.01%	4164
2024 Q2	$147K	Buy	+10,181	New	+$149K	﹤0.01%	4658

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

LPL Financial's VRNA Position: Q4 2025 in Review

LPL Financial sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 20,946 shares — an estimated $2.24M sold.

LPL Financial first reported a position in VRNA in Q2 2024 and held it in 6 quarters. The position peaked at $6.37M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

LPL Financial reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
LPL Financial sold 20,946 Verona Pharma shares in Q4 2025, an estimated $2.24M.
LPL Financial first reported a position in Verona Pharma in Q2 2024 and held it in 6 quarters.
LPL Financial's Verona Pharma position peaked at $6.37M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on LPL Financial's 13F filing for Q4 2025, filed 11 Feb 2026.